DEPARTMENT OF HEALTH AND HUMAN SERVICES 
PUBLIC HEALTH SERVICE 
NATIONAL INSTITUTES OF HEALTH 
RECOMBINANT DNA ADVISORY COMMITTEE 
HUMAN GENE THERAPY SUBCOMMITTEE 
MINUTES OF MEETING 1 
December 7, 1987 
The Human Gene Therapy Subcommittee, Recombinant DNA Advisory Committee, was convened 
at 9:10 a.m. on December 7, 1987, at the National Institutes of Health, Building 31 C, Conference 
Room 9, 9000 Rockville Pike, Bethesda, Maryland 20892. Dr. LeRoy Walters was Chair. In 
accordance with Public Law 92-463, the meeting was open to the public. The following were 
present for all or part of the meeting. 
Subcommittee members: 
Judith Areen 
Alexander Capron 
James Childress 
Charles Epstein 
Robert Erickson 
The subcommittee roster 
Susan Gottesman 
Maurice Mahoney 
Robert Murray 
Robertson Parkman 
LeRoy Walters 
is attached. 
Anne Witherby 
William Gartland 
(Executive Secretary) 
Liaison representatives: 
Robert Cook-Deegan, Office of Technology Assessment 
Charles McCarthy, National Institutes of Health 
Henry Miller, Food and Drug Administration 
Ad hoc consultant: 
Richard Mulligan, Whitehead Institute for Biomedical Research 
National Institutes of Health staff: 
W. French Anderson, NHLBI 
Stanley Barban, NIAID 
Fred Bergmann, NIGMS 
Kenneth Cornetta, NHLBI 
Ken Culver, NCI 
Irene Eckstrand, NIGMS 
’The subcommittee is advisory to the Recombinant DNA Advisory Committee, and its 
recommendations should not be considered as final or accepted. 
Recombinant DNA Research, Volume 13 
[91] 
